Cytrx Cp (CYTR) 0.60 $CYTR
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against CytRx Corporation
Marketwire Canada - Mon Aug 01, 3:26PM CDT
OKLAHOMA CITY, OK--(Marketwired - Aug 1, 2016) - On July 25, 2016, a class action lawsuit was filed in the United States District Court for the Central District of California against CytRx Corporation (NASDAQ: CYTR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is November 18, 2014 through July 11, 2016.
CYTR: 0.60 (-0.05)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR
GlobeNewswire - Fri Jul 29, 4:49PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against CytRx Corporation ("CytRx" or the "Company"
(NASDAQ:CYTR) and certain of its officers. The class action, filed in United States District Court Central District of California, and docketed under 16-cv-05666, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired CytRx securities between November 18, 2014 and July 11, 2016, inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
CYTR: 0.60 (-0.05)
CYTR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving CytRx Corporation and a Lead Plaintiff Deadline of September 23, 2016
GlobeNewswire - Fri Jul 29, 9:11AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased CytRx Corporation (NASDAQ:CYTR) securities between November 18, 2014 and July 11, 2016.
CYTR: 0.60 (-0.05)
What Awaits ACUR & Other Drug Stocks this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:43AM CDT
Medical is one of the six sectors that are projected to record positive earnings growth this quarter.
ABT: 45.29 (+0.54), JNJ: 125.40 (+0.17), GILD: 80.46 (+0.99), NVLS: 4.76 (+0.08), CYTR: 0.60 (-0.05), CEMP: 18.50 (+0.53), ACUR: 1.91 (-0.03), NVS: 83.07 (-0.19)
CytRx Reports Second Quarter 2016 Financial Results
PR Newswire - Fri Jul 29, 8:00AM CDT
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended June 30, 2016, and provided an overview of recent corporate developments and upcoming milestones for its research and development programs.
CYTR: 0.60 (-0.05)
Can Ecolab (ECL) Spring an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:10PM CDT
Ecolab Inc. (ECL) is slated to announce second-quarter 2016 earnings results on Aug 2, 2016.
ZTS: 50.40 (-0.07), CYTR: 0.60 (-0.05), NKTR: 17.76 (+0.47), ECL: 118.67 (+0.29)
Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:57AM CDT
Weight management service provider Weight Watchers International Inc. is scheduled to release second-quarter 2016 results on Aug 4.
ZTS: 50.40 (-0.07), CYTR: 0.60 (-0.05), WTW: 11.15 (-0.78), NKTR: 17.76 (+0.47)
Should You Buy CytRx (CYTR) Ahead of Earnings?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:50AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and CytRx Corporation (CYTR) may be one such company
CYTR: 0.60 (-0.05)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CytRx Corporation - CYTR
BusinessWire - Wed Jul 27, 10:45AM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of CytRx Corporation securities (NASDAQ: CYTR) from November 18, 2014 through July 11, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for CytRx investors under the federal securities laws.
CYTR: 0.60 (-0.05)
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against CytRx Corporation
Marketwire Canada - Mon Aug 01, 3:26PM CDT
OKLAHOMA CITY, OK--(Marketwired - Aug 1, 2016) - On July 25, 2016, a class action lawsuit was filed in the United States District Court for the Central District of California against CytRx Corporation (NASDAQ: CYTR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is November 18, 2014 through July 11, 2016.
CYTR: 0.60 (-0.05)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR
GlobeNewswire - Fri Jul 29, 4:49PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against CytRx Corporation ("CytRx" or the "Company"
(NASDAQ:CYTR) and certain of its officers. The class action, filed in United States District Court Central District of California, and docketed under 16-cv-05666, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired CytRx securities between November 18, 2014 and July 11, 2016, inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". CYTR: 0.60 (-0.05)
CYTR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving CytRx Corporation and a Lead Plaintiff Deadline of September 23, 2016
GlobeNewswire - Fri Jul 29, 9:11AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased CytRx Corporation (NASDAQ:CYTR) securities between November 18, 2014 and July 11, 2016.
CYTR: 0.60 (-0.05)
What Awaits ACUR & Other Drug Stocks this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:43AM CDT
Medical is one of the six sectors that are projected to record positive earnings growth this quarter.
ABT: 45.29 (+0.54), JNJ: 125.40 (+0.17), GILD: 80.46 (+0.99), NVLS: 4.76 (+0.08), CYTR: 0.60 (-0.05), CEMP: 18.50 (+0.53), ACUR: 1.91 (-0.03), NVS: 83.07 (-0.19)
CytRx Reports Second Quarter 2016 Financial Results
PR Newswire - Fri Jul 29, 8:00AM CDT
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended June 30, 2016, and provided an overview of recent corporate developments and upcoming milestones for its research and development programs.
CYTR: 0.60 (-0.05)
Can Ecolab (ECL) Spring an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:10PM CDT
Ecolab Inc. (ECL) is slated to announce second-quarter 2016 earnings results on Aug 2, 2016.
ZTS: 50.40 (-0.07), CYTR: 0.60 (-0.05), NKTR: 17.76 (+0.47), ECL: 118.67 (+0.29)
Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:57AM CDT
Weight management service provider Weight Watchers International Inc. is scheduled to release second-quarter 2016 results on Aug 4.
ZTS: 50.40 (-0.07), CYTR: 0.60 (-0.05), WTW: 11.15 (-0.78), NKTR: 17.76 (+0.47)
Should You Buy CytRx (CYTR) Ahead of Earnings?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:50AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and CytRx Corporation (CYTR) may be one such company
CYTR: 0.60 (-0.05)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CytRx Corporation - CYTR
BusinessWire - Wed Jul 27, 10:45AM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of CytRx Corporation securities (NASDAQ: CYTR) from November 18, 2014 through July 11, 2016, both dates inclusive (the "Class Period"
. The lawsuit seeks to recover damages for CytRx investors under the federal securities laws. CYTR: 0.60 (-0.05)
